Autoantibodies against type I IFNs in patients with life-threatening COVID-19
2020 · Science · 2,815 citations
https://doi.org/10.1126/science.abd4585
A
Alberto Pesci
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
122
Papers
9.8K
Citations
32
h-index
52
i10-index
Alberto Pesci is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis & Sarcoidosis and Beryllium Toxicity Research & Pneumonia and Respiratory Infections. The author has an h-index of 32, co-authored 104 publications.
Papers by this author
worksInborn errors of type I IFN immunity in patients with life-threatening COVID-19
2020 · Science · 2,377 citations
https://doi.org/10.1126/science.abd4570
Airways Remodeling Is a Distinctive Feature of Asthma and Is Related to Severity of Disease
1997 · CHEST Journal · 389 citations
https://doi.org/10.1378/chest.111.4.852
Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis
2018 · JAMA · 221 citations
https://doi.org/10.1001/jama.2018.6129
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
2019 · The Lancet Respiratory Medicine · 99 citations
https://doi.org/10.1016/s2213-2600(19)30172-9
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak
2021 · Critical Care · 87 citations
https://doi.org/10.1186/s13054-021-03502-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat